Medinotec Inc. financial data

Symbol
MDNC on OTC
Industry
Surgical & Medical Instruments & Apparatus
Location
Office 202, Gezeri Building, Naif, Po Box 488083, Dubai, United Arab Emirates
State of incorporation
Nevada
Fiscal year end
February 28
Latest financial report
10-Q - Q2 2024 - Jul 12, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 764 %
Debt-to-equity 99.2 %
Return On Equity -15 % -50.8%
Return On Assets -7.53 %
Operating Margin 12 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 11.7M shares 0%
Common Stock, Shares, Outstanding 11.7K shares 0%
Entity Public Float 3.66M USD 0%
Common Stock, Value, Issued 11.7K USD 0%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 6.93M USD +468%
Cost of Revenue -3.88M USD -544%
Research and Development Expense -35.1K USD -6.05%
Selling and Marketing Expense -59.5K USD +31.7%
General and Administrative Expense -2.06M USD -166%
Operating Income (Loss) 829K USD +559%
Nonoperating Income (Expense) -889K USD -546%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -59.9K USD +79.1%
Income Tax Expense (Benefit) 127K USD +6347%
Net Income (Loss) Attributable to Parent -340K USD -27.1%
Earnings Per Share, Basic -0.02 USD/shares +33.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Accounts Receivable, after Allowance for Credit Loss, Current 359K USD +48.7%
Other Assets, Current 99K USD -46.9%
Assets, Current 3.94M USD +8.5%
Property, Plant and Equipment, Net 316K USD -12.3%
Operating Lease, Right-of-Use Asset 56.8K USD
Assets 4.32M USD -7.96%
Accounts Payable, Current 1.59K USD -99.1%
Employee-related Liabilities, Current 1.21K USD -92.5%
Liabilities, Current 772K USD +853%
Operating Lease, Liability, Noncurrent 33.9K USD
Liabilities 2.07M USD -0.05%
Common Stocks, Including Additional Paid in Capital 3.31M USD
Accumulated Other Comprehensive Income (Loss), Net of Tax 96.2K USD -25.5%
Stockholders' Equity Attributable to Parent 2.25M USD -14.2%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 2.58M USD
Liabilities and Equity 4.32M USD -7.96%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 246K USD
Net Cash Provided by (Used in) Financing Activities -542K USD -798%
Net Cash Provided by (Used in) Investing Activities -6.06K USD
Common Stock, Shares Authorized 200M shares +6.23%
Common Stock, Shares, Issued 11.7M shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -290K USD -147%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 2.52M USD -7.05%
Interest Paid, Excluding Capitalized Interest, Operating Activities 10.6K USD +3.99%
Deferred Tax Assets, Valuation Allowance -177K USD
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure -99%
Deferred Tax Assets, Gross 237K USD +117%
Payments to Acquire Property, Plant, and Equipment -6.06K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -373K USD -147%
Property, Plant and Equipment, Gross 1.59M USD -0.58%
Operating Lease, Liability, Current 25.6K USD
Deferred Income Tax Expense (Benefit) -98.5K USD -260%
Deferred Tax Assets, Operating Loss Carryforwards 17.3K USD
Current Income Tax Expense (Benefit) -100K USD -4987%
Preferred Stock, Shares Authorized 20M shares 0%
Additional Paid in Capital 3.3M USD
Current Federal Tax Expense (Benefit) 12.3K USD
Operating Leases, Future Minimum Payments, Due in Two Years 31.2K USD
Depreciation, Depletion and Amortization 23.2K USD +24.4%
Operating Leases, Future Minimum Payments Due, Next Twelve Months 30.6K USD
Deferred Tax Assets, Net of Valuation Allowance 59.6K USD -45.3%
Operating Leases, Future Minimum Payments, Due in Three Years 13K USD
Operating Leases, Future Minimum Payments Due 59.4K USD
Interest Expense -270K USD -7.89%